For neurodevelopmental disorders (NDDs), a molecular diagnosis is key for management,
predicting outcome, and counseling. Often, routine DNA-based tests fail to establish a genetic …

Objective To evaluate the effect of chenodeoxycholic acid treatment on disease progression
in cerebrotendinous xanthomatosis (CTX). Methods In this retrospective cohort study, we …

Routine diagnostic screening of inborn errors of metabolism (IEM) is currently performed by
different targeted analyses of known biomarkers. This approach is time-consuming, targets a …

Early diagnosis and dietary treatment do not prevent long-term complications, which mostly
affect the central nervous system in classical galactosemia patients. The clinical outcome of …

In order to study the pathophysiology of hypoglycemia in idiopathic ketotic hypoglycemia (KH),
glucose kinetics during fasting in patients with KH were determined. A fasting test was …

… In addition, H Huidekoper reports institutional reimbursement from BioMarin Europe Ltd,
outside of the submitted work. M Mazurkiewicz-Bełdzińska reports personal fees from Biogen; …

Purpose Cerebrotendinous xanthomatosis (CTX) is a treatable hereditary disorder caused
by the deficiency of sterol 27-hydroxylase, which is encoded by the CYP27A1 gene. Different …

… 24 to 48 h afterwards, as in the literature, IARs are also reported in the 48 h after alglucosidase
… , Huidekoper H. eP030502 Safety of home-based infusion of alglucosidase alfa in adults …

Background: Pompe disease is a lysosomal storage disease characterised by skeletal and
respiratory muscle weakness. Since 2006, enzyme replacement therapy (ERT) with …

Multiple acyl‐CoA dehydrogenase deficiency (MADD) is an ultra‐rare inborn error of
mitochondrial fatty acid oxidation (FAO) and amino acid metabolism. Individual phenotypes and …